Pharmaceuticals Middle East

Middle East COPD Treatment Market Analysis, 2024–2034

Middle East COPD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Device, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Middle East · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $995.1 Mn Estimated value
Estimate 2025 $1.05 Bn 4.4% of the global market
Projected 2034 $1.65 Bn 57.8% Adds $605.2 Mn over 9 forecast years
CAGR 2025–2034 5.2% Faster than 11% of 180 Pharmaceuticals markets here
Key players 5
  • Middle East is 4.4% of the global market.
  • Among regions, the largest is North America at $10.92 Bn.
  • Fastest growing: Africa at 5.7% a year.
  • Middle East ranks 5th of 6 by size among regions.

Market size projection

Middle East

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$605.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
COPD Treatment Market market size by year, Middle East
YearMarket sizeChange that yearSince 2025
2024 (estimate) $995.1 Mn — —
2025 (base) $1.05 Bn +$51.7 Mn —
2026 (forecast) $1.10 Bn +$54.4 Mn +5.2%
2027 (forecast) $1.16 Bn +$57.3 Mn +10.7%
2028 (forecast) $1.22 Bn +$60.2 Mn +16.4%
2029 (forecast) $1.28 Bn +$63.4 Mn +22.5%
2030 (forecast) $1.35 Bn +$66.7 Mn +28.8%
2031 (forecast) $1.42 Bn +$70.1 Mn +35.5%
2032 (forecast) $1.49 Bn +$73.8 Mn +42.6%
2033 (forecast) $1.57 Bn +$77.6 Mn +50%
2034 (forecast) $1.65 Bn +$81.7 Mn +57.8%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $23.80 Bn
  2. North America $10.92 Bn
  3. US $10.33 Bn
  4. APAC $5.48 Bn
  5. Europe $3.77 Bn
  6. China $2.16 Bn
  7. Canada $2.02 Bn
  8. Japan $1.40 Bn
  9. Latin America $1.13 Bn
  10. Middle East (this report) $1.05 Bn
  11. Germany $942.3 Mn
  12. France $681.3 Mn
  13. Brazil $686.8 Mn
  14. UK $553.2 Mn
  15. Spain $502.6 Mn
  16. Italy $489.8 Mn
  17. Ecuador $468.6 Mn
  18. India $421.5 Mn
  19. Mexico $389.5 Mn
  20. Saudi Arabia $393.8 Mn
  21. Africa $366.3 Mn
  22. Australia $321.1 Mn
  23. New Zealand $270.1 Mn
  24. Russia $235.4 Mn
  25. South Africa $174.1 Mn
  26. UAE $103.5 Mn
  27. Egypt $69.0 Mn
  28. Philippines $52.7 Mn
  29. Malaysia $42.2 Mn
  30. Hong Kong $33.1 Mn
  31. Thailand $32.3 Mn
  32. Singapore $28.6 Mn
  33. Kenya $18.9 Mn

The Middle East COPD Treatment Market Analysis Executive Summary

COPD treatments help people with chronic obstructive lung disease breathe more easily and have fewer flare-ups.

Key segments of the COPD Treatment market include drug class (LAMA/LABA Combinations, Triple Therapy and Biologics) and device (Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers).

Middle East COPD Treatment Market Dynamics

Market Growth Drivers

Rising rates of chronic disease linked to diabetes, ageing, smoking and pollution, plus new treatments that slow disease, are driving the COPD Treatment market.

Opportunity

Earlier screening, new drug classes and home-based care give the COPD Treatment market room to grow.

Market Restraints

Late diagnosis, high prices of new medicines, limited specialist care and poor adherence hold back the COPD Treatment market.

Competitive Landscape for COPD Treatment Market in Middle East

The COPD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for COPD Treatment Market in Middle East

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for COPD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Middle East.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in COPD Treatment right now, from free public sources.

Clinical trials

6 active trials in UAE, Saudi Arabia, Yemen, Jordan, Lebanon, Qatar, Syria, Palestine and Iraq

Recruiting, about to start, or running now. Counted across the 9 countries we report on in Middle East.

Top trial sponsors (worldwide)

  1. AstraZeneca 16 active trials on ClinicalTrials.gov (opens in a new tab)
  2. GSK PLC 7 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Haisco Pharmaceutical Group Co., Ltd. 7 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Sanofi 6 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Fisher & Paykel 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 399 papers since 2021 (worldwide)

  1. Reimagining COPD treatment: are biologics the next frontier? Expert opinion on pharmacotherapy, 2026
  2. Contemporary Inhaled Maintenance Therapy Patterns and Treatment Progression for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Findings from the DUALITY Patient Journey Study. Pulmonary therapy, 2026
  3. Targeting Accelerated Aging in COPD: The AMICO (A Trial of Metformin In COpd) Trial Design. COPD, 2026
  4. Non-Coding RNA Regulates Pyroptosis in Chronic Obstructive Pulmonary Disease. Phenomics (Cham, Switzerland), 2026
  5. Mechanism of Action of Qingjin Huazhuo Formula in Treating Chronic Obstructive Pulmonary Disease Based on Proteomics, Traditional Chinese Medicine Component Analysis, and Network Pharmacology. Applied biochemistry and biotechnology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

COPD Treatment in context

Questions, answered with public data

How many clinical trials on COPD Treatment are running in Middle East?
6 studies are recruiting, active or about to start in Middle East, counted across the 9 countries we report on there.[1]
How much research is published on COPD Treatment?
PubMed lists 399 papers added since January 2021 that match this market, worldwide.[2]

[1] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Middle East. Retrieved 12 Nov 2026.

[2] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about COPD Treatment in Middle East? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Airway Management Devices: Critical Tools in EmergenciesKeeping the airway open is the first step in saving a life. More than half of deaths in low- and… Anaesthesia and Respiratory Devices: Lessons After COVIDMore than 5 billion people lack access to safe, affordable medical oxygen. COVID-19 exposed gaps in… Snoring and Sleep Apnoea Devices: Sleeping BetterAn estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Middle East

See all
Same topic, other categories

Related on respiratory and smoking

See the topic